ConductScience.org, home

Paper32550997

Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.

Cescon E and 8 others. ACS Med Chem Lett, 2020. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors. Papers, record 32550997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32550997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.
PubMed
Journal
ACS Med Chem Lett
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2021-06-12
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cescon EEleonora
2Bolcato GGiovanni
3Federico SStephanie
4Bissaro MMaicol
5Valentini AAlice
6Ferlin MGMaria Grazia
7Spalluto GGianpiero
8Sturlese MMattia
9Moro SStefano

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111161704Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization.Exp Cell Res2001https://conductscience.org/library/papers/11161704PubMed
229630366Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.J Med Chem2018https://conductscience.org/library/papers/29630366PubMed
319125657Empirical scoring functions for advanced protein-ligand docking with PLANTS.J Chem Inf Model2009https://conductscience.org/library/papers/19125657PubMed
49126849Development and validation of a genetic algorithm for flexible docking.J Mol Biol1997https://conductscience.org/library/papers/9126849PubMed
518574471CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.Oncogene2008https://conductscience.org/library/papers/18574471PubMed
624904820The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.Front Oncol2014https://conductscience.org/library/papers/24904820PubMed
722235331Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.PLoS One2012https://conductscience.org/library/papers/22235331PubMed
823351099Consensus docking: improving the reliability of docking in a virtual screening context.J Chem Inf Model2013https://conductscience.org/library/papers/23351099PubMed
920577972Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.Med Res Rev2011https://conductscience.org/library/papers/20577972PubMed
1023861943CK1δ kinase activity is modulated by Chk1-mediated phosphorylation.PLoS One2013https://conductscience.org/library/papers/23861943PubMed
1123919824Ligand-protein interactions of selective casein kinase 1δ inhibitors.J Med Chem2013https://conductscience.org/library/papers/23919824PubMed
1214761950Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.J Biol Chem2004https://conductscience.org/library/papers/14761950PubMed
1310924763Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.Neurobiol Aging2000https://conductscience.org/library/papers/10924763PubMed
1431376410Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).Gene2019https://conductscience.org/library/papers/31376410PubMed
1515722192The casein kinase 1 family: participation in multiple cellular processes in eukaryotes.Cell Signal2005https://conductscience.org/library/papers/15722192PubMed
1628609096Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.ACS Chem Neurosci2017https://conductscience.org/library/papers/28609096PubMed
1724592867Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.J Med Chem2014https://conductscience.org/library/papers/24592867PubMed
1826769969Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43.J Biol Chem2016https://conductscience.org/library/papers/26769969PubMed
1926035098DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.Molecules2015https://conductscience.org/library/papers/26035098PubMed
207665585Role of COOH-terminal phosphorylation in the regulation of casein kinase I delta.J Biol Chem1995https://conductscience.org/library/papers/7665585PubMed

See all 23 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
39174535Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39174535PubMed
39073853Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.J Med Chem2024https://conductscience.org/library/papers/39073853PubMed
38931832Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?Pharmaceutics2024https://conductscience.org/library/papers/38931832PubMed
37259317"Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37259317PubMed
36315402Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations.J Chem Inf Model2022https://conductscience.org/library/papers/36315402PubMed
35874609Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study.Front Mol Biosci2022https://conductscience.org/library/papers/35874609PubMed
33324805Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors.ACS Omega2020https://conductscience.org/library/papers/33324805PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CSNK1D1453PubTator's text mininghttps://conductscience.org/library/genes/1453

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32550997

GET https://conductscience.org/api/papers/v1/32550997/references?page=2